Acumen Pharmaceuticals, Inc. ABOS
Set alert
0.24 USD 0.00 0.00%
At close
0.23 -0.01 -4.05%
Pre-market · Nov 3, 9:02 AM ET
Day range unavailable
0.198 52-week range 3.60
- YTD
- -88.64%
- 1 year
- -89.00%
- Open
- —
- Prev close
- 0.2397
- Mkt cap
- 17.34M
- Vol
- 0
- Avg vol
- 2.10M
- EPS
- -1.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.17
- Beta
- 0.04
- Short ratio
- 6.61
- Inst. own
- 78.46%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 2.48
- 200-d avg
- 2.89
- 1y target
- 10.80
1D chart
Signals (104)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | 3:58 PM | 17 hours ago |
| SMA: Bullish | 3:46 PM | 17 hours ago |
| SMA: Bearish | 3:45 PM | 17 hours ago |
| SMA: Bullish | 3:44 PM | 17 hours ago |
| MACD: Buy Signal | 3:40 PM | 17 hours ago |
| SMA: Bearish | 3:28 PM | 17 hours ago |
| MACD: Sell Signal | 3:28 PM | 17 hours ago |
| SMA: Bearish | 3:27 PM | 17 hours ago |
| SMA: Bullish | 3:25 PM | 17 hours ago |
| MACD: Buy Signal | 3:25 PM | 17 hours ago |
| SMA: Bearish | 3:24 PM | 17 hours ago |
| SMA: Bullish | 3:22 PM | 17 hours ago |
| SMA: Bullish | 3:22 PM | 17 hours ago |
| SMA: Bearish | 3:21 PM | 17 hours ago |
| SMA: Bullish | 3:20 PM | 17 hours ago |
| SMA: Bearish | 3:16 PM | 17 hours ago |
| SMA: Bearish | 3:16 PM | 17 hours ago |
| SMA: Bullish | 3:15 PM | 17 hours ago |
| SMA: Bullish | 3:14 PM | 17 hours ago |
| SMA: Bearish | 3:13 PM | 17 hours ago |
Newest 20 of 104.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 10.80 +4405.6% upside
Now 0.2397
- Target (low)
- 6.00
- Target (mean)
- 10.80
- Target (high)
- 15.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.36582 | -0.42 – -0.30745 | -0.29 | -26.1% | 0 | 0.0% | 3 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -1.32 | -1.51 – -0.99693 | -1.08 | -22.4% | 0 | 0.0% | 3 |
| Next year | -1.53 | -1.69 – -1.34 | -1.32 | -15.5% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 3, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 15, 2024 | UBS | Maintained | Buy | Buy |
| Aug 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 25, 2024 | Citigroup | Initiated | — | Buy |
| May 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 31, 2024 | UBS | Maintained | Buy | Buy |
| Mar 27, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 12, 2023 | Deutsche Bank | Initiated | — | Buy |
| Aug 9, 2023 | Credit Suisse | Reiterated | Outperform | Outperform |
| Aug 9, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 17, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 18, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 28, 2023 | Credit Suisse | Maintained | — | Outperform |
| Mar 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Feb 2, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Nov 15, 2022 | Credit Suisse | Maintained | — | Outperform |
| Oct 5, 2022 | BTIG | Maintained | — | Buy |
| Jul 15, 2022 | BTIG | Initiated | — | Buy |
| Jun 30, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 29, 2022 | Credit Suisse | Maintained | — | Outperform |
| Jan 21, 2022 | B of A Securities | Upgrade | Neutral | Buy |
| Jul 26, 2021 | UBS | Initiated | — | Buy |
| Jul 26, 2021 | B of A Securities | Initiated | — | Neutral |
| Jul 26, 2021 | Credit Suisse | Initiated | — | Outperform |
| Jul 26, 2021 | Stifel | Initiated | — | Buy |